Epidemiological Study of Dry Eye Disease in Stavanger: Dry Eye Disease in Patients Treated With Intravitreal Injections (EPISTA1)

Helse Stavanger HF

Status: Invitation-only

Conditions: Dry Eye

Treatments: Diagnostic Test: Oculus Keratograph. Schirmer test. Tear fluid sample.

Study type: Observational

Funder types: Other

Identifiers

NCT04458012

EPISTA1

Details and patient eligibility

About

To investigate prevalence of dry eye disease in Norwegian patients with age-related macular degeneration receiving intravitreal injections, as well as to reveal possible risk factors of DED in this population.

Full description

Questionaires (OSDI, McMonnies) and clinical investigation using the Oculus 5 Keratograph for objective ocular surface evaluation. Tear fluid samples will be collected for later biochemical analysis.

Enrollment: 300 estimated patients

Sex: All

Ages: 50 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• AMD diagnosis
• Treated with intravitreal injection agents

Exclusion criteria

• Not able to cooperate